An investigation into the origins of the sensation of pain has led to the development of a novel and durable treatment for inflammatory pain that could be a promising alternative to opioids. The preclinical research was conducted ...
Oct 4, 2021
1
139
CBD use increased 50% in the past four years, according to a new survey published Wednesday in the Journal of the American Medical Association.
Dec 16, 2023
0
0
Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects, according to new Northwestern Medicine research. A study with mice suggests the drugs could act like a bad electrician, ...
Feb 18, 2012
1
0
Atypical antipsychotics, though effective for treating disorders like schizophrenia, bipolar disorder, and depression, gives patients a heightened risk of developing new-onset diabetes. A new data mining study, however, has ...
Jun 2, 2016
1
21
Post-traumatic osteoarthritis—caused by degraded cartilage that cushions the ends of bones in joints—occurs after a joint injury. With the knowledge that PTOA will lead to earlier onset and faster progression of osteoarthritis ...
Sep 1, 2021
0
128
A newly developed small-molecular radiopharmaceutical pair has successfully visualized and treated melanoma in a preclinical study, according to new research presented at the Society of Nuclear Medicine and Molecular Imaging ...
Jun 15, 2022
0
8
The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects.
Dec 16, 2011
0
0
Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown. A side effect that then often occur is involuntary ...
Jan 7, 2021
0
72
Even after decades of research, cancer remains difficult to treat, in part because of its ability to evade the body's natural defenses found in the immune system.
Apr 22, 2019
0
53
Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds ...
Oct 9, 2013
0
1
